Ex Parte Cannon et al - Page 13

                Appeal 2007-1139                                                                             
                Application 10/052,664                                                                       
                ENABLEMENT                                                                                   
                      Claim 1 stands rejected under 35 U.S.C. § 112, first paragraph,                        
                because, “since the claimed invention is not supported by either a specific                  
                and substantial asserted utility or a well established utility . . . , one skilled in        
                the art clearly would not know how to use the claimed invention.”  (Answer                   
                15.)  Because we are reversing the utility rejection, we also reverse the                    
                enablement rejection of claim 1.                                                             
                                              CONCLUSION                                                     
                   In summary, as the Examiner has failed to establish that the polypeptide                  
                of claim 1 lacks a patentable utility, we reverse.                                           

                                                REVERSED                                                     










                Ssc                                                                                          

                ROCHE PALO ALTO LLC                                                                          
                PATENT LAW DEPARTMENT M/S A2-250                                                             
                3431 HILLVIEW AVENUE                                                                         
                PALO ALTO, CA 94304                                                                          



                                                     13                                                      

Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13

Last modified: September 9, 2013